ClinicalTrials.gg
Drug

Risperidone clinical trials

Also written Risperdal, LY03004 and TV-46000.

studies test it
262
open now
10
in phase 3
74
first study started
1994

How each study uses Risperidone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Risperidone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 Dec 1993 · RISPERDAL · NDA 020272 (FDA, Drugs@FDA)
European Union
14 Feb 2022 · Okedi · EMEA/H/C/005406 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Risperidone
186
Risperdal Consta
9
Risperidone ISM 100 mg
5
Risperidone oral solution
4
Risperidone 1 MG
3

Brand

Risperdal
51
PERSERIS
1

Development codes

LY03004
3
TV-46000
2
DLP-114
1

In one entry with another drug

Given together, or one or the other

Sertraline and Risperidone
2
quetiapine, risperidone
2

Studies by the year they started

248 studies that test it; most in 2003 (25); 1 more planned to start later

Studies that test Risperidone, by start year
YearStudies
19941
19952
19965
19975
19982
19995
200010
200124
200214
200325
200425
200512
200612
20078
200813
20096
20105
20114
20127
20136
20145
20157
20166
201711
20185
20195
20202
20215
20221
20233
20242
20253
20262

Who runs them

Industry 108 · Other 154

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (27) · Janssen, LP (10) · Northwell Health (8) · Washington University School of Medicine (6) · Janssen Pharmaceutica N.V., Belgium (6) · University of California, Los Angeles (5) · Janssen Research & Development, LLC (5) · Rovi Pharmaceuticals Laboratories (5)

Often tested with

Tested in the same studies.

Olanzapine (42) · Aripiprazole (32) · Quetiapine (25) · Paliperidone (14) · Ziprasidone (10) · Valproic Acid (9) · Haloperidol (8) · Amisulpride (6)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test Risperidone, phase 3 first.

Studies

Open first, then newest update. How each study uses Risperidone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 262

See all 262 studies that test Risperidone →

Given beside what is tested · 29 — Risperidone is usual care or a partner of the new treatment

Showing 20 of 29.

As the comparator · 66 — what is tested is compared with Risperidone

Showing 20 of 66.

Codes

What other systems call Risperidone · ClinicalTrials.gg INT008659

  • MeSH (NLM) D018967RisperidoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) L6UH7ZF8HCRISPERIDONEConfirmed FDA, NLM, Wikidata
  • RxNorm 35636Confirmed FDA, Wikidata
  • Wikidata Q412443risperidoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29416RisperidoneOne source FDA
  • DrugBank DB00734One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.